| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0258 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 |
| filingDate |
2003-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801d1afdc22a3ebf5ec988f842ae4ff9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be59f9007db183024e18c3c7410c3618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c2b08e0caf4b2c6472aa7fe6ca0ae4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93b68b976fab7cc0862add64d3eb1065 |
| publicationDate |
2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005074813-A1 |
| titleOfInvention |
Model for testing immunogenicity of peptides |
| abstract |
Assay methods for determining whether a peptide is likely to be immunogenic are based on a computer modeling of binding to a Class II MHC DR1 receptor. This is confirmed by competitive inhibition binding assays. The peptides are useful for eliciting an immune response for vaccination or the production of antibodies or T-cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7625571-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008021686-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8706421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005025787-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7894995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8396671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192039-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8121797-B2 |
| priorityDate |
1993-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |